Brief: Summit Therapeutics Announces Proposed Public Offering Of Common Stock
BRIEF-Summit Therapeutics Announces Proposed Public Offering Of Common Stock June 9 (Reuters) - Summit Therapeutics Inc SMMT.O:
SUMMIT THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
SUMMIT THERAPEUTICS - COMMENCES $500 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK
SUMMIT THERAPEUTICS - PROCEEDS TO FUND IVONESCIMAB RD, WORKING CAPITAL, AND GENERAL CORPORATE PURPOSES
Source text: ID:nBwbQbzkna
Further company coverage: SMMT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Summit Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
Summit Therapeutics rebounds after pulling stock offering
Brief: Summit Therapeutics Withdraws Proposed Underwritten Public Offering Effective- SEC Filing
Summit Therapeutics falls on launching $500 mln stock offering